Under the National Health and Medical Research Council Act 1992, NHMRC administers the Medical Research Endowment Account (MREA) in order to provide assistance to institutions and people engaged in medical research and for medical research training.
NHMRC awards new grants worth around $800 million each year from the MREA. Expenditure of the MREA is spread across a variety of grant types, including Project Grants, Program Grants, Development Grants, Partnership Projects, a range of scholarships and fellowships, Centres of Research Excellence, Targeted Calls for Research and several collaborative schemes with international partners.
Feedback from the research sector indicates that the work required to prepare and evaluate the high numbers of grant applications that will not be funded is placing an unsustainable burden on applicants and peer reviewers. Concerns have also been raised that many researchers, especially those at early and mid-career stages, are also becoming discouraged from pursuing research and that there are disincentives to exploring new areas of research.
To address these challenges, an over-arching review of NHMRC’s grant program is being undertaken to determine whether the suite of funding schemes can be streamlined and adapted to current circumstances, while continuing to support the best Australian research and researchers for the benefit of human health.
This Review follows on from the Fellowship Consultation conducted by NHMRC last year. A number of submissions to that consultation suggested there is a need for a strategic, whole-of-system review of NHMRC’s funding program.
- CEO update announcing the Structural Review
- March update: NHMRC's progress with the Structural Review
- May update: NHMRC’s consultation plans and progress
- Public Consultation now open - NEW
- Frequently Asked Questions
Terms of Reference
The Review will examine and provide advice to the CEO of NHMRC about:
- the structure of the grant program, including:
- the impact of the grant program on the health and medical research sector;
- the flexibility of the grant program to meet future needs for health and medical research in Australia; and
- alternative models and their potential to overcome the current challenges.
The Review will consider relevant overseas experience with medical research grant programs. NHMRC will also consider feedback provided in response to its Fellowship Consultation.
Conduct of the review
The Review will be conducted by the Office of NHMRC, reporting to the CEO. An Expert Advisory Group will provide advice and assistance to NHMRC in examining the current grant program and possible alternative models. This Group is chaired by Professor Steve Wesselingh and members have a variety of different experiences and perspectives. The membership of the Group is provided below.
The CEO will draw on the advice of the Expert Advisory Group and NHMRC Research Committee, with additional advice from NHMRC Council, Health Translation Advisory Committee, Health Innovation Advisory Committee and the Principal Committee Indigenous Caucus.
External consultation will be undertaken through public forums and a period of public consultation, expected to commence in July 2016.
We anticipate that the Review will be finalised around the end of 2016.
Membership of the Expert Advisory Group
- Professor Steven Wesselingh (Chair)
- Professor Philip Clarke
- Professor Jonathan Craig
- Professor Gemma Figtree
- Ms Christine Gunson
- Associate Professor Noel Hayman
- Professor Doug Hilton
- Professor Kathryn North
- Professor Robyn Owens
- Dr Phoebe Phillips
- Professor Rodney Phillips
- Professor Robert Ramsay
- Professor Debra Rickwood
- Professor Melanie Wakefield